Glen Harbor Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $145K | Buy |
5,264
+192
| +4% | +$5.29K | ﹤0.01% | 1101 |
|
|
2019
Q2 | $168K | Hold |
5,072
| – | – | ﹤0.01% | 1062 |
|
|
2019
Q1 | $178K | Hold |
5,072
| – | – | ﹤0.01% | 1023 |
|
|
2018
Q4 | $168K | Hold |
5,072
| – | – | ﹤0.01% | 996 |
|
|
2018
Q3 | $255K | Buy |
5,072
+928
| +22% | +$46.7K | 0.01% | 972 |
|
|
2018
Q2 | $248K | Hold |
4,144
| – | – | 0.01% | 902 |
|
|
2018
Q1 | $190K | Buy |
4,144
+176
| +4% | +$8.07K | ﹤0.01% | 983 |
|
|
2017
Q4 | $158K | Buy |
3,968
+832
| +27% | +$33.1K | ﹤0.01% | 1051 |
|
|
2017
Q3 | $125K | Buy |
3,136
+416
| +15% | +$16.6K | ﹤0.01% | 1067 |
|
|
2017
Q2 | $117K | Buy |
2,720
+1,280
| +89% | +$55.1K | ﹤0.01% | 1046 |
|
|
2017
Q1 | $45K | Buy |
1,440
+144
| +11% | +$4.5K | ﹤0.01% | 1141 |
|
|
2016
Q4 | $33K | Buy |
+1,296
| New | +$33K | ﹤0.01% | 1147 |
|